Creative Financial Designs’s AIM ImmunoTech AIM Stock Holding History

Creative Financial Designs’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18	Buy	+30	New	+$30	﹤0.01%	2150

Other funds holding AIM

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Creative Financial Designs's AIM Position: Q1 2026 in Review

Creative Financial Designs opened a new position in AIM ImmunoTech (AIM) in Q1 2026: 30 shares worth $18. The stake represents ﹤0.01% of the portfolio and ranks #2150 among its holdings.

18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

Creative Financial Designs held 30 shares of AIM ImmunoTech worth $18 as of Q1 2026.
AIM ImmunoTech was a new Creative Financial Designs position in Q1 2026.
AIM ImmunoTech made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #2150 holding.
18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.